India, Jan. 6 -- Johnson & Johnson (JNJ) on Tuesday reported positive topline results from the Phase 2b JASMINE study of nipocalimab in adults with systemic lupus erythematosus (SLE). The study met i... Read More
India, Jan. 6 -- Genprex, Inc. (GNPX) on Tuesday reported preliminary preclinical data showing its diabetes gene therapy candidate GPX-002 improved glucose control in Type 2 diabetes animal models. I... Read More
India, Jan. 5 -- Polyrizon Ltd. (PLRZ), Monday announced positive results from a new in-vitro pre-clinical study, evaluating the allergen-blocking performance of its PL-14 Allergy Blocker formulation ... Read More
India, Jan. 5 -- Genelux Corporation (GNLX) on Monday reported interim results from two ongoing trials evaluating Olvi-Vec in patients with progressive lung cancer: a Phase 1b/2 study in small cell lu... Read More
India, Jan. 5 -- Zenas BioPharma (ZBIO) reported positive results from the Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease. Obexelimab met the primary endpoint, demonstrating 5... Read More
India, Jan. 5 -- Two experienced folks from Silicon Valley who helped create some of the biggest social media platforms are now supporting a new app aimed at tackling the negative effects of today's s... Read More
India, Jan. 5 -- Wegmans Food Markets has started using facial and voice recognition tech to keep an eye on customers at its two locations in New York City, as reported in the news. Signs in the stor... Read More
India, Jan. 5 -- Qualcomm Technologies (QCOM) at CES, on Monday announced that it has rolled out a next-gen robotics framework that combines hardware, software, and cutting-edge AI to boost the real-w... Read More
India, Jan. 4 -- Hyundai Motor Group has shared its strategic vision for 2026, with Executive Chair Euisun Chung presenting priorities aimed at driving customer-focused transformation, strengthening e... Read More
India, Jan. 4 -- The Board of Directors of Olam Group Limited announced that regulatory approvals from most jurisdictions have been obtained, while approvals from two jurisdictions remain in process. ... Read More